349 related articles for article (PubMed ID: 19151727)
1. Regulation of cardiovascular development and integrity by the heart of glass-cerebral cavernous malformation protein pathway.
Kleaveland B; Zheng X; Liu JJ; Blum Y; Tung JJ; Zou Z; Sweeney SM; Chen M; Guo L; Lu MM; Zhou D; Kitajewski J; Affolter M; Ginsberg MH; Kahn ML
Nat Med; 2009 Feb; 15(2):169-76. PubMed ID: 19151727
[TBL] [Abstract][Full Text] [Related]
2. Cerebral cavernous malformations arise independent of the heart of glass receptor.
Zheng X; Riant F; Bergametti F; Myers CD; Tang AT; Kleaveland B; Pan W; Yang J; Tournier-Lasserve E; Kahn ML
Stroke; 2014 May; 45(5):1505-1509. PubMed ID: 24643410
[TBL] [Abstract][Full Text] [Related]
3. ccm2-like is required for cardiovascular development as a novel component of the Heg-CCM pathway.
Rosen JN; Sogah VM; Ye LY; Mably JD
Dev Biol; 2013 Apr; 376(1):74-85. PubMed ID: 23328253
[TBL] [Abstract][Full Text] [Related]
4. Structural basis of the junctional anchorage of the cerebral cavernous malformations complex.
Gingras AR; Liu JJ; Ginsberg MH
J Cell Biol; 2012 Oct; 199(1):39-48. PubMed ID: 23007647
[TBL] [Abstract][Full Text] [Related]
5. Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity.
Stockton RA; Shenkar R; Awad IA; Ginsberg MH
J Exp Med; 2010 Apr; 207(4):881-96. PubMed ID: 20308363
[TBL] [Abstract][Full Text] [Related]
6. Differential angiogenesis function of CCM2 and CCM3 in cerebral cavernous malformations.
Zhu Y; Wu Q; Xu JF; Miller D; Sandalcioglu IE; Zhang JM; Sure U
Neurosurg Focus; 2010 Sep; 29(3):E1. PubMed ID: 20809750
[TBL] [Abstract][Full Text] [Related]
7. CCM3 signaling through sterile 20-like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations.
Zheng X; Xu C; Di Lorenzo A; Kleaveland B; Zou Z; Seiler C; Chen M; Cheng L; Xiao J; He J; Pack MA; Sessa WC; Kahn ML
J Clin Invest; 2010 Aug; 120(8):2795-804. PubMed ID: 20592472
[TBL] [Abstract][Full Text] [Related]
8. Structural basis for the disruption of the cerebral cavernous malformations 2 (CCM2) interaction with Krev interaction trapped 1 (KRIT1) by disease-associated mutations.
Fisher OS; Liu W; Zhang R; Stiegler AL; Ghedia S; Weber JL; Boggon TJ
J Biol Chem; 2015 Jan; 290(5):2842-53. PubMed ID: 25525273
[TBL] [Abstract][Full Text] [Related]
9. Mesenteric cysts, lymphatic leak, and cerebral cavernous malformation in a proband with KRIT1-related disease.
Moller-Hansen A; Huynh S; Boerkoel CF; Chin HL
Am J Med Genet A; 2022 Jan; 188(1):332-335. PubMed ID: 34558799
[TBL] [Abstract][Full Text] [Related]
10. Ccm3 functions in a manner distinct from Ccm1 and Ccm2 in a zebrafish model of CCM vascular disease.
Yoruk B; Gillers BS; Chi NC; Scott IC
Dev Biol; 2012 Feb; 362(2):121-31. PubMed ID: 22182521
[TBL] [Abstract][Full Text] [Related]
11. Heg1 and Ccm1/2 proteins control endocardial mechanosensitivity during zebrafish valvulogenesis.
Donat S; Lourenço M; Paolini A; Otten C; Renz M; Abdelilah-Seyfried S
Elife; 2018 Feb; 7():. PubMed ID: 29364115
[TBL] [Abstract][Full Text] [Related]
12. A single-center study on 140 patients with cerebral cavernous malformations: 28 new pathogenic variants and functional characterization of a PDCD10 large deletion.
Nardella G; Visci G; Guarnieri V; Castellana S; Biagini T; Bisceglia L; Palumbo O; Trivisano M; Vaira C; Scerrati M; Debrasi D; D'Angelo V; Carella M; Merla G; Mazza T; Castori M; D'Agruma L; Fusco C
Hum Mutat; 2018 Dec; 39(12):1885-1900. PubMed ID: 30161288
[TBL] [Abstract][Full Text] [Related]
13. A two-hit mechanism causes cerebral cavernous malformations: complete inactivation of CCM1, CCM2 or CCM3 in affected endothelial cells.
Pagenstecher A; Stahl S; Sure U; Felbor U
Hum Mol Genet; 2009 Mar; 18(5):911-8. PubMed ID: 19088124
[TBL] [Abstract][Full Text] [Related]
14. Molecular Genetic Features of Cerebral Cavernous Malformations (CCM) Patients: An Overall View from Genes to Endothelial Cells.
Riolo G; Ricci C; Battistini S
Cells; 2021 Mar; 10(3):. PubMed ID: 33810005
[TBL] [Abstract][Full Text] [Related]
15. Functional analyses of human and zebrafish 18-amino acid in-frame deletion pave the way for domain mapping of the cerebral cavernous malformation 3 protein.
Voss K; Stahl S; Hogan BM; Reinders J; Schleider E; Schulte-Merker S; Felbor U
Hum Mutat; 2009 Jun; 30(6):1003-11. PubMed ID: 19370760
[TBL] [Abstract][Full Text] [Related]
16. High-throughput sequencing of the entire genomic regions of CCM1/KRIT1, CCM2 and CCM3/PDCD10 to search for pathogenic deep-intronic splice mutations in cerebral cavernous malformations.
Rath M; Jenssen SE; Schwefel K; Spiegler S; Kleimeier D; Sperling C; Kaderali L; Felbor U
Eur J Med Genet; 2017 Sep; 60(9):479-484. PubMed ID: 28645800
[TBL] [Abstract][Full Text] [Related]
17. Cerebral cavernous malformation proteins at a glance.
Draheim KM; Fisher OS; Boggon TJ; Calderwood DA
J Cell Sci; 2014 Feb; 127(Pt 4):701-7. PubMed ID: 24481819
[TBL] [Abstract][Full Text] [Related]
18. EndMT contributes to the onset and progression of cerebral cavernous malformations.
Maddaluno L; Rudini N; Cuttano R; Bravi L; Giampietro C; Corada M; Ferrarini L; Orsenigo F; Papa E; Boulday G; Tournier-Lasserve E; Chapon F; Richichi C; Retta SF; Lampugnani MG; Dejana E
Nature; 2013 Jun; 498(7455):492-6. PubMed ID: 23748444
[TBL] [Abstract][Full Text] [Related]
19. Cerebral cavernous malformations: from CCM genes to endothelial cell homeostasis.
Fischer A; Zalvide J; Faurobert E; Albiges-Rizo C; Tournier-Lasserve E
Trends Mol Med; 2013 May; 19(5):302-8. PubMed ID: 23506982
[TBL] [Abstract][Full Text] [Related]
20. Mutations in 2 distinct genetic pathways result in cerebral cavernous malformations in mice.
Chan AC; Drakos SG; Ruiz OE; Smith AC; Gibson CC; Ling J; Passi SF; Stratman AN; Sacharidou A; Revelo MP; Grossmann AH; Diakos NA; Davis GE; Metzstein MM; Whitehead KJ; Li DY
J Clin Invest; 2011 May; 121(5):1871-81. PubMed ID: 21490399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
